Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by <SUP>89</SUP>Zr Immuno-PET

Citations

WEB OF SCIENCE

13
Citations

SCOPUS

13

초록

We developed an immuno-PET technique that monitors modulation of tumor CD133 expression, which is required for the success of CD133-targeted therapies. Methods. Anti-CD133 antibodies were subjected to sulfhydryl moiety-specific Zr-89 conjugation. Zr-89-CD133 IgG was evaluated for specific activity and radiolabel stability. Colon cancer cells underwent binding assays and Western blotting. Biodistribution and PET studies were performed in mice. Results. Zr-89-CD133 IgG showed excellent target specificity with 97.2 & PLUSMN;0.7% blocking of HT29 cell binding by an excess antibody. Intravenous Zr-89-CD133 IgG followed biexponential blood clearance and showed CD133-specific uptake in HT29 tumors. Zr-89-CD133 IgG PET/CT and biodistribution studies confirmed high HT29 tumor uptake with lower activities in the blood and normal organs. In HT29 cells, celecoxib dose-dependently decreased CD133 expression and Zr-89-CD133 IgG binding that reached 19.9 & PLUSMN;2.1% (P < 0.005) and 50.3 & PLUSMN;10.9% (P < 0.001) of baseline levels by 50 mu M, respectively. Celecoxib treatment of mice significantly suppressed tumor CD133 expression to 67.5 & PLUSMN;7.8% of controls (P < 0.005) and reduced tumor Zr-89-CD133 IgG uptake from 15.5 & PLUSMN;1.4% at baseline to 12.3 & PLUSMN;2.0%ID/g (P < 0.01). Celecoxib-induced CD133 reduction in HT29 cells and tumors was associated with substantial suppression of AKT activation. There were also reduced HIF-1 alpha accumulation and I kappa B alpha/NF kappa B phosphorylation. Conclusion. Zr-89-CD133 IgG PET provides high-contrast tumor imaging and monitors celecoxib treatment-induced modulation of tumor CD133 expression, which was found to occur through AKT inhibition. This technique may thus be useful for screening drugs that can effectively suppress colon cancer stem cells.

키워드

COLORECTAL-CANCER; STEM-CELLS; INFLAMMATION; METASTASIS; THERAPY; PATHWAY; TARGETS
제목
Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by <SUP>89</SUP>Zr Immuno-PET
저자
Jung, Kyung-Ho; Lee, Jin Hee; Kim, Mina; Lee, Eun Ji; Cho, Young Seok; Lee, Kyung-Han
DOI
10.1155/2022/4906934
발행일
2022-01-07
유형
Article
저널명
Molecular Imaging
권
2022